Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/first-line-chemotherapy-with-capecitabine-and-temozolomide-in-patients-odwZ5mohiJ
References (34)
-
J. Hornick, Christine Frauenhoffer, Susanne Hooshmand, D. Ryan, P. Enzinger, J. Meyerhardt, Jeffrey Clark, K. Stuart, C. Fuchs, andMark Redston (2008)
O-Methylguanine DNA Methyltransferase Deficiency and Response toTemozolomide-BasedTherapy in Patients with Neuroendocrine Tumors -
C. Moertel, J. Hanley, L. Johnson (1980)
Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.The New England journal of medicine, 303 21
-
Fine (4216)
Effective Treatment of Neuroendocrine Tumors with Capecitabine and TemozolomideASCO Abstract No.
-
P. Hodul, J. Strosberg, L. Kvols (2008)
Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?Cancer control : journal of the Moffitt Cancer Center, 15 4
-
M. Kulke, K. Stuart, C. Earle, P. Bhargava, Jeffrey Clark, P. Enzinger, J. Meyerhardt, M. Attawia, C. Lawrence, C. Fuchs (2006)
A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
-
L. Kvols, M. Buck (1987)
Chemotherapy of endocrine malignancies: a review.Seminars in oncology, 14 3
-
K. Oberg, B. Eriksson (2005)
Endocrine tumours of the pancreas.Best practice & research. Clinical gastroenterology, 19 5
-
R. Fine, D. Fogelman, S. Schreibman (2005)
Effective treatment of neuroendocrine tumors With temozolomide and capecitabineJournal of Clinical Oncology, 23
-
P. Ruszniewski, D. Malka (2000)
Hepatic Arterial Chemoembolization in the Management of Advanced Digestive Endocrine TumorsDigestion, 62
-
J. Norton, R. Warren, M. Kelly, M. Zuraek, R. Jensen (2003)
Aggressive surgery for metastatic liver neuroendocrine tumors.Surgery, 134 6
-
K. Bock, P. Cottier, E. Freis, F. Gross, W. Peart, J. Robertson (1974)
RAUWOLFIA DERIVATIVES AND CANCERThe Lancet, 304
-
M. Kouvaraki, J. Ajani, P. Hoff, R. Wolff, Douglas Evans, R. Lozano, James Yao (2004)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 23
-
J. Strosberg, Junsung Choi, A. Cantor, L. Kvols (2006)
Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.Cancer control : journal of the Moffitt Cancer Center, 13 1
-
J. Sarmiento, G. Heywood, J. Rubin, D. Ilstrup, D. Nagorney, F. Que (2003)
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.Journal of the American College of Surgeons, 197 1
-
I. Murray-Lyon, A. Eddleston, Roger Williams, Michael Brown, B. Hogbin, Alan Bennett, J. Edwards, KeithW. Taylor (1968)
Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.Lancet, 2 7574
-
R. Ramanathan, A. Cnaan, R. Hahn, P. Carbone, D. Haller (2001)
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.Annals of oncology : official journal of the European Society for Medical Oncology, 12 8
-
D. Kwekkeboom, W. Herder, B. Kam, C. Eijck, M. Essen, P. Kooij, R. Feelders, M. Aken, E. Krenning (2008)
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 13
-
R. Ramanathan, A. Carbone, D. Hailed (2005)
Phase II trial of dacarbazine ( DTIC ) in advanced pancreatic islet cell carcinoma . Study of the Eastern Cooperative Oncology GroupE 6282 -
Kulke (2003)
A Phase 2 Study to Evaluate the Safety and Efficacy of SU11248 in Patients with Unresectable Neuroendocrine TumorsProceedings of ASCO., 22
-
I. Madeira, B. Terris, M. Voss, A. Denys, A. Sauvanet, J. Fléjou, V. Vilgrain, J. Belghiti, P. Bernades, P. Ruszniewski (1998)
Prognostic factors in patients with endocrine tumours of the duodenopancreatic areaGut, 43
-
J. Strosberg, A. Nasir, D. Coppola, M. Wick, L. Kvols (2009)
Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.Human pathology, 40 9
-
M. Kulke, Bingyan Wu, D. Ryan, P. Enzinger, A. Zhu, Jeffrey Clark, C. Earle, A. Michelini, C. Fuchs (2006)
A Phase II Trial of Irinotecan and Cisplatin in Patients with Metastatic Neuroendocrine TumorsDigestive Diseases and Sciences, 51
-
C. Moertel, L. Kvols, M. O’connell, J. Rubin (1991)
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasmsCancer, 68
-
J. Strosberg, N. Gardner, L. Kvols (2009)
Survival and Prognostic Factor Analysis in Patients With Metastatic Pancreatic Endocrine CarcinomasPancreas, 38
-
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
-
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.Journal of the National Cancer Institute, 92 3
-
(2009)
Pancreatic neuroendocrine tumors: the impact of surgical resection on survival -
T. Halfdanarson, J. Rubin, M. Farnell, C. Grant, G. Petersen (2008)
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Endocrine-related cancer, 15 2
-
Jun Yao, A. Phan, David Chang, C. Jacobs, J. Mares, A. Rashid, F. Meric-Bernstam (2006)
Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
-
C. Moertel, Myrto Lefkopoulo, S. Lipsitz, R. Hahn, D. Klaassen (1992)
Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.The New England journal of medicine, 326 8
-
W. Isacoff, R. Moss, A. Pecora, R. Fine (2006)
Temozolomide/capecitabine therapy for metastatic neuroendocrine tumors of the pancreas. A retrospective review.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
-
M. Kulke, K. Stuart, P. Enzinger, D. Ryan, Jeffrey Clark, A. Muzikansky, M. Vincitore, A. Michelini, C. Fuchs (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 3
-
J. Murakami, You-jin Lee, S. Kokeguchi, H. Tsujigiwa, J. Asaumi, H. Nagatsuka, K. Fukui, M. Kuroda, N. Tanaka, N. Matsubara (2007)
Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines.Oncology reports, 17 6
-
Sanjay Gupta, James Yao, K. Ahrar, M. Wallace, F. Morello, D. Madoff, R. Murthy, M. Hicks, J. Ajani (2003)
Hepatic Artery Embolization and Chemoembolization for Treatment of Patients with Metastatic Carcinoid Tumors: The M.D. Anderson ExperienceThe Cancer Journal, 9
- Publisher
- Wiley
- Copyright
- "Copyright © 2011 Wiley Subscription Services, Inc., A Wiley Company"
- ISSN
- 0008-543X
- eISSN
- 1097-0142
- DOI
- 10.1002/cncr.25425
- pmid
- 20824724
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Cancer – Wiley
Published: Mar 15, 2012
Keywords: ; ; ; ;